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undergoing standard phototherapy. In patients (e.g. psoriasis)
with long-term maintenance phototherapy, the determination of
serum folate may be advisable.
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PI3K/AKT/mTOR pathway
activation in actinic cheilitis and
lip squamous cell carcinomas
Editor
Lower lip squamous cell carcinoma (LLSCC) is one of the most
common cancers of the head and neck.1 Actinic cheilitis (AC) is
a potentially malignant disorder of the lip, and it is estimated
that 3.07% of AC cases undergo malignant transformation.2 Lip
carcinogenesis is directly associated with exposure to ultraviolet
(UV) radiation and tobacco.1,2 The molecular circuitry involved
in this process, however, remains poorly understood. The identi-
fication of deregulated pathways during the process of carcino-
genesis may help in the identification of molecular markers
capable of identifying early cellular transformation. The activa-
tion of the pathway comprised by phosphatidylinositol-3-kinase
(PI3K), protein kinase B (Akt) and mammalian target of
rapamycin (mTOR) is considered a key event in many types of
tumours due to its ability to modulate important oncogenic out-
comes.3-5 Remarkably, this pathway had never been fully investi-
gated in lip carcinogenesis until now. Herein, an
immunohistochemical assessment of PI3K Kinase p110a,
AktSer473 phosphorylation and mTORC1 activation through
analysis of ribosomal protein S6 kinase (RPS6) phosphorylation
was performed in 38 cases of AC, 40 cases of LLSCC, and nine
cases of normal lips (NL), as baseline controls. For each case, an
immunoreactive score (IRS) was designated by multiplying the
percentage of positive cells (0 – 0% to 10%; 1 – 11% to 50%;
and 2 – 51% to 100%) by the staining intensity (0 – absent; 1 –
weak; 2 – moderate; 3 – intense). Differences in the IRS were
assessed through statistical analysis.
PI3K Kinase p110a showed a significant increase in
immunoreactivity from NL to LLSCC (P < 0.01) and from AC
to LLSCC (P < 0.05) (Fig. 1), suggesting that the activation of
this protein is associated with the acquisition of the malignant
phenotype. PI3K pathway alterations occur in 30% to 66% of
head and neck squamous cell carcinomas and are also linked to
advanced disease.5 The oncogenic triggering of this pathway
commonly occurs by activating mutations in the p110a isoform
of PI3K or through the loss of the PTEN tumour suppressor.5
The pAktSer473 marker was significantly higher in AC
(P < 0.001) and in LLSCC (P < 0.001), both compared to NL
(Fig. 1), suggesting that Akt modification occurs as an early
event in lip carcinogenesis. The Akt pathway is considered an
important element in cell survival and proliferation after UV
exposure,6 which could justify why AC presents high levels of
Figure 1 Representative images of immunohistochemical label-
ling of PI3K Kinase p110a, pAktSer473, and pRPS6 in NL, AC and
LLSCC (original magnification, 9400). Mean expression of PI3K
Kinase p110a, pAktSer473, and pRPS6 in NL, AC and LLSCC
(*P < 0.05; **P < 0.01; ***P < 0.001 – Kruskal–Wallis test followed
by Dunn’s post hoc test adjusted for Bonferroni error correction).
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pAkt. Moreover, other groups have previously demonstrated an
increase of pAktThr303 in oral squamous cell carcinoma (OSCC)
and oral epithelial dysplasia compared to non-dysplastic oral tis-
sue,4 corroborating with the present findings. Several PI3K/Akt/
mTOR target drugs are available, and their use as a topical treat-
ment for AC deserves to be further investigated.
The activation of mTORC1 that results in phosphorylation of
RPS6 was significantly decreased in LLSCC when compared to
NL (P < 0.05), contrasting with the previous proteins (Fig. 1).
These findings agree with previous studies conducted with
OSCC and leukoplakia.4,7 Moreover, our group has previously
studied the PI3K/PTEN/mTOR pathway in lip keratoacanthoma
(KA),8 a well-differentiated, well-keratinized tumour that may
originate in the pilosebaceous unit. We observed a strong posi-
tivity for pRPS6 along with a lower expression of pAktSer473. Our
hypothesis is that mTORC1, but not mTORC2, is associated
with KA development, and the absence of pAktSer473 could be
related to its low invasive capacity, whereas the increase of
pRPS6 would be related to the tumour differentiation pattern.
Based on our results, it is possible to conclude that PI3K Kinase
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Poor prognosis of drug-induced
and acute graft-versus-host
disease-induced epidermal
necrolysis in bone marrow/stem
cell transplant recipients: a
retrospective case series
Editor
Toxic epidermal necrolysis (TEN) and stage IV acute graft-
versus-host disease (AGVHD) are uncommon severe complica-
tions in bone marrow/haematopoietic stem cell transplant
(BMT/HSCT) recipients and are often clinically indistinguish-
able.1–7 We sought to identify discriminating clinical and patho-
logical features between drug-induced EN (DI-EN) and acute
graft AGVHDI-EN and determine their prognosis.
We retrospectively reviewed the charts of patients who under-
went allo-BMT/HSCT at our institution from January 1997 to
2017 (IRB 16-029-MUHC). Patients were ≥ 18 years of age,
underwent allo-BMT/HSCT and developed epidermal necrolysis,
defined as detachment of full-thickness epidermis. To collate a
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